Increased serum concentration of soluble CD14 is a prognostic marker in Gram-positive sepsis

Clinical Immunology and Immunopathology

Volumn 80, Issue 3 II, 1996, Pages 307-310

  Burgmann, Heinz ^a   Winkler, Stefan ^a   Locker, Gottfried J ^a   Presterl, Elisabeth ^a   Laczika, Klaus ^a   Staudinger, Thomas ^a   Knapp, Sylvia ^a   Thalhammer, Florian ^a   Wenisch, Christoph ^a   Zedwitz Liebenstein, Konstantin ^a   Frass, Michael ^a   Graninger, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAM POSITIVE SEPSIS; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SERUM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; BACTEREMIA; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SOLUBILITY;

EID: 0029797188     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0128     Document Type: Article

References (26)

1. Durieux, J. J., Vita, N., Popescu, O., Guette, F., Calzada Wack, J., Munker, R., Schmidt, R. E., Lupker, J., Ferrara, P., Ziegler Heitbrock, H. W., et al., The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes. Eur. J. Immunol. 24, 2006-2012, 1994.
2. Juan, T. S., Kelley, M. J., Johnson, D. A., Busse, L. A., Hailman, E., Wright, S. D., and Lichenstein, H. S., Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270, 1382-1387, 1995.
3. Eggesbo, J. B., Hjermann, L., Lund, P. K., Joo, G. B., Ovstebo, R., and Kierulf, P., LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine 6, 521-529, 1994.
4. Labeta, M. O., Durieux, J. J., Spagnoli, G., Fernandez, N., Wijdenes, J., and Herrmann, R., CD14 and tolerance to lipopolysaccharide: Biochemical and functional analysis. Immunology 80, 415-423, 1993.
5. Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B., and Wright, S. D., Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176, 1665-1671, 1992.
6. Landmann, R., Zimmerli, W., Sansano, S., Link, S., Hahn, A., Glauser, M. P., and Calandra, T., Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171, 639-644, 1995.
7. Nockher, W. A., Bergmann, L., and Scherberich, J. E., Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98, 369-374, 1994.
8. Striz, I., Zheng, L., Wang, Y. M., Pokorna, H., Bauer, P. C., and Costabel, U., Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am. J. Respir. Crit. Care Med. 151, 544-547, 1995.
9. Schöpf, R. E., Dobmeyer, J., Dobmeyer, T., and Morsches, B., Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis. Dermatology 186, 45-49, 1993.
10. Wuthrich, B., Kagi, M. K., and Joller Jemelka, H., Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch. Dermatol. Res. 284, 339-342, 1992.
11. Nockher, W. A., Wigand, R., Schoeppe, W., and Scherberich, J. E., Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 96, 15 -19, 1994.
12. Endo, S., Inada, K., Kasai, T., Takakuwa, T., Nakae, H., Kikuchi, M., Yamashita, H., and Yoshida, M., Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF). Res. Commun. Chem. Pathol. Pharmacol. 84, 17-25, 1994.
13. Krüger, C., Schütt, C., Obertacke, U., Joka, T., Müller, F. E., Knöller, J., Köller, M., König, W., and Schönfeld, W., Serum CD14 levels in polytraumatized and severly burned patients. Clin. Exp. Immunol. 85, 297-301, 1991.
14. Bone, R. C., Sepsis and its complications: The clinical problem. Crit. Care Med. 22, S8-11, 1994.
15. Calandra, T., Baumgartner, J. D., Grau, G. E., Wu, M. M., Lambert, P. H., Schellekens, J., Verhoef, J., and Glauser, M. P., Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J. Infect. Dis. 161, 982-987, 1990.
16. Lin, R. Y., Astiz, M. E., Saxon, J. C., Saha, D. C., and Rackow, E. C., Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit. Care Med. 22, 1595-1602, 1994.
17. Billiau, A., and Vandekerckhove, F., Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 21, 559-573, 1991.
18. Calandra, T., and Glauser, M. P., Cytokines and septic shock. Diagn. Microbiol. Infect. Dis. 13, 377-381, 1990.
19. Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., and Balk, R. A., Sepsis syndrome: A valid clinical entity. Crit. Care Med. 18, 389-393, 1990.
20. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C., CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433, 1990.
21. Birkenmaier, C., Hong, Y. S., and Horn, J. K., Modulation of the endotoxin receptor (CD14) in septic patients. J. Trauma 32, 473-478, 1992.
22. Maliszewski, C. R., CD14 and immune response to lipopolysaccharide [letter; comment]. Science 252, 1321-1322, 1991.
23. Grunwald, U., Krüger, C., and Schütt, C., Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function. Cire. Shock 39, 220-225, 1993.
24. Schütt, C., Schilling, T., Grunwald, U., Schönfeld, W., and Krüger, C., Endotoxin-neutralizing capacity of soluble CD14. Res. Immunol. 143, 71-78, 1992.
25. Schütt, C., Schilling, T., and Krüger, C., sCD14 prevents endotoxin inducible oxidative burst response of human monocytes. Allerg. Immunol. Leipz. 37, 159-164, 1991.
26. Wurfel, M. M., Hailman, E., and Wright, S. D., Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181, 1743-1754, 1995.